Ages2Come
Menu
View all results →
Categories
⚡ Breaking
Larry Page’s flying car company Pivotal loses its CEO Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics SEC proposes transfer agent rule, sets event to figure out round-the-clock U.S. trading China dissented from G20 statement opposing 'cheap exports' flooding market, Bessent says Tim Cook to be paid $47mn as Apple’s executive chair Are all TVs at risk from burn-in? Here's how to avoid the problem altogether At G20 Meeting, Scott Bessent Accuses China of Flooding the World With Cheap Exports Will self-flying planes transform the skies? The Range Rover Electric: Specs, Price, Availability Blue Origin wins NASA contract for telecommunications on Mars Larry Page’s flying car company Pivotal loses its CEO Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics SEC proposes transfer agent rule, sets event to figure out round-the-clock U.S. trading China dissented from G20 statement opposing 'cheap exports' flooding market, Bessent says Tim Cook to be paid $47mn as Apple’s executive chair Are all TVs at risk from burn-in? Here's how to avoid the problem altogether At G20 Meeting, Scott Bessent Accuses China of Flooding the World With Cheap Exports Will self-flying planes transform the skies? The Range Rover Electric: Specs, Price, Availability Blue Origin wins NASA contract for telecommunications on Mars
Startups / General

AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?

Source: cnbc July 10, 2026 · 22:00
For years, AstraZeneca has commanded one of the richest valuations among large European pharma companies on the assumption that it consistently delivers results.
Read original article ← Back to General

The original article opens on the publisher's website.

More from General

View topic →